Evidence map

ArticleDrug design, development and therapy2025

Influencing Factors of Treatment Response to Rituximab in Refractory Membranous Nephropathy.

Lianzi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40859975